Real-time enrollment status for this sepsis clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 11:41 PM UTC
| NCT Number | NCT06637904 |
| Recruiting Status | Recruiting |
| Condition | Sepsis |
| Phase | NA |
| Target Enrollment | 300 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Inflammatix |
| Last Updated on CT.gov | January 8, 2025 (Jan 8, 2025) |
As of July 19, 2026: Clinical trial NCT06637904 is currently recruiting participants. This na study for sepsis is actively seeking new participants at 2 locations across the United States. The study is sponsored by Inflammatix. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06637904 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06637904 was last updated Jan 8, 2025 (January 8, 2025). HelloStudys verifies this status automatically.